Forskning
Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital
Udgivet

The acute brain response to levodopa heralds dyskinesias in Parkinson disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Melanopsin retinal ganglion cell loss in Alzheimer's disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. 25-Hydroxyvitamin D and symptomatic ischemic stroke: An Original Study and Meta-Analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Regulation of regional cerebral blood flow during and between migraine attacks

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Discrete finger sequences are widely represented in human striatum

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The influence of prolonged strength training upon muscle and fat in healthy and chronically diseased older adults

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Probing Context-Dependent Modulations of Ipsilateral Premotor-Motor Connectivity in Relapsing-Remitting Multiple Sclerosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVE: In Parkinson disease (PD), long-term treatment with the dopamine precursor levodopa gradually induces involuntary "dyskinesia" movements. The neural mechanisms underlying the emergence of levodopa-induced dyskinesias in vivo are still poorly understood. Here, we applied functional magnetic resonance imaging (fMRI) to map the emergence of peak-of-dose dyskinesias in patients with PD.

METHODS: Thirteen PD patients with dyskinesias and 13 PD patients without dyskinesias received 200mg fast-acting oral levodopa following prolonged withdrawal from their normal dopaminergic medication. Immediately before and after levodopa intake, we performed fMRI, while patients produced a mouse click with the right or left hand or no action (No-Go) contingent on 3 arbitrary cues. The scan was continued for 45 minutes after levodopa intake or until dyskinesias emerged.

RESULTS: During No-Go trials, PD patients who would later develop dyskinesias showed an abnormal gradual increase of activity in the presupplementary motor area (preSMA) and the bilateral putamen. This hyperactivity emerged during the first 20 minutes after levodopa intake. At the individual level, the excessive No-Go activity in the predyskinesia period predicted whether an individual patient would subsequently develop dyskinesias (p < 0.001) as well as severity of their day-to-day symptomatic dyskinesias (p < 0.001).

INTERPRETATION: PD patients with dyskinesias display an immediate hypersensitivity of preSMA and putamen to levodopa, which heralds the failure of neural networks to suppress involuntary dyskinetic movements.

OriginalsprogEngelsk
TidsskriftAnnals of Neurology
Vol/bind75
Udgave nummer6
Sider (fra-til)829-36
Antal sider8
ISSN0364-5134
DOI
StatusUdgivet - jun. 2014

ID: 44733929